ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 104 filers reported holding ARATANA THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $105,000 | +43.8% | 20,400 | 0.0% | 0.00% | +50.0% |
Q1 2019 | $73,000 | -41.6% | 20,400 | 0.0% | 0.00% | -60.0% |
Q4 2018 | $125,000 | +5.0% | 20,400 | 0.0% | 0.01% | +25.0% |
Q3 2018 | $119,000 | +36.8% | 20,400 | 0.0% | 0.00% | +33.3% |
Q2 2018 | $87,000 | -3.3% | 20,400 | 0.0% | 0.00% | -25.0% |
Q1 2018 | $90,000 | -15.9% | 20,400 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $107,000 | -14.4% | 20,400 | 0.0% | 0.00% | -20.0% |
Q3 2017 | $125,000 | -8.8% | 20,400 | +7.9% | 0.01% | -16.7% |
Q2 2017 | $137,000 | +37.0% | 18,900 | 0.0% | 0.01% | +20.0% |
Q1 2017 | $100,000 | -26.5% | 18,900 | 0.0% | 0.01% | -28.6% |
Q4 2016 | $136,000 | -19.0% | 18,900 | +5.6% | 0.01% | -22.2% |
Q3 2016 | $168,000 | +48.7% | 17,900 | 0.0% | 0.01% | +50.0% |
Q2 2016 | $113,000 | +14.1% | 17,900 | 0.0% | 0.01% | 0.0% |
Q1 2016 | $99,000 | +73.7% | 17,900 | 0.0% | 0.01% | +50.0% |
Q4 2015 | $57,000 | -38.0% | 17,900 | +64.2% | 0.00% | -33.3% |
Q3 2015 | $92,000 | – | 10,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 5,184,942 | $31,784,000 | 4.70% |
AWM Investment Company, Inc. | 1,562,517 | $9,578,000 | 1.67% |
Opaleye Management Inc. | 420,000 | $2,574,000 | 0.91% |
MPM ASSET MANAGEMENT LLC | 250,000 | $1,533,000 | 0.75% |
GENERAL AMERICAN INVESTORS CO INC | 867,600 | $5,318,000 | 0.50% |
Grandeur Peak Global Advisors, LLC | 538,363 | $3,300,000 | 0.50% |
Redmond Asset Management, LLC | 55,941 | $343,000 | 0.16% |
WOODSTOCK CORP | 88,303 | $541,000 | 0.10% |
CADENCE CAPITAL MANAGEMENT LLC | 173,808 | $1,065,000 | 0.07% |
Sheaff Brock Investment Advisors, LLC | 71,000 | $435,000 | 0.06% |